<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2020.1012441</article-id><article-id pub-id-type="publisher-id">ACM-39164</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20201200000_36252216.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  Castor单分支支架与单烟囱支架在胸主动脉疾病中重建左侧锁骨下动脉的疗效分析及评价
  Analysis and Evaluation of the Efficacy of Castor Single-Branch Stent and Single-Chimney Stent in the Reconstruction of the Left Subclavian Artery in Thoracic Aortic Disease
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>邱</surname><given-names>德强</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>李</surname><given-names>君</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>辛</surname><given-names>海</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>刘</surname><given-names>伟丽</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>官</surname><given-names>笑梅</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>豪夫</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>青岛大学附属医院，山东 青岛</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><aff id="aff2"><addr-line>青岛大学，山东 青岛</addr-line></aff><pub-date pub-type="epub"><day>07</day><month>12</month><year>2020</year></pub-date><volume>10</volume><issue>12</issue><fpage>2918</fpage><lpage>2925</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    目的：总结分析Castor单分支支架与单烟囱支架在治疗胸主动脉疾病中重建左锁骨下动脉的经验与体会。方法：回顾性分析2015年12月至2019年6月期间我院因胸主动脉疾病就诊的42例患者临床资料。42例患者中，应用Castor单分支支架19例，其中Stanford B型主动脉夹层13例，主动脉瘤5例，主动脉溃疡1例；应用单烟囱支架的23例，其中Stanford B型主动脉夹层14例，主动脉瘤7例，主动脉溃疡2例，比较两组在围手术期和随访期间的结果，尤其是在主动脉重塑以及内漏等并发症方面。结果：Castor单分支支架及单烟囱支架手术技术成功率均为100%且住院期间无死亡、脑卒中及截瘫患者。19例Castor支架组患者术后I型内漏1人，23例烟囱支架组患者，I型内漏7例，随访期间无死亡。Castor支架组随访时间为(18.9 &#177; 5.9)个月，分支支架通畅率为100%，烟囱支架随访时间为(15.5 &#177; 8.7)个月，烟囱支架通畅率为91.3%。结论：Castor单分支支架与单烟囱支架均可用于治疗累积左锁骨下动脉的胸主动脉疾病，近中期通畅率满意。Castor支架对左侧锁骨下动脉成角要求较低，术后假腔完全血栓化概率高，对于左锁骨下动脉成角大的患者优先考虑Castor支架，远期效果有待继续随访观察。
    Objective: To summarize and analyze the experience of Castor single branch stent and single chimney stent in the reconstruction of the left subclavian artery in the treatment of thoracic aortic disease. Methods: Clinical data of 42 patients admitted to our hospital for aortic disease from December 2015 to June 2019 were retrospectively analyzed. Among the 42 patients, 19 patients were treated with Castor single-branch stent, including 13 patients with Stanford B aortic dissection, 5 patients with aortic aneurysm and 1 patient with aortic ulcer. Among the 23 patients treated with single-chimney stent, 14 were treated with Stanford B aortic dissection, 7 with aortic aneurysm, and 2 with aortic ulcer. Results: The success rate of Castor stent and chimney stent was 100% and there were no death, stroke or paraplegia patients. There was 1 type I endoleak of Castor stent group, and 7 type I endoleak of chimney stent group, both groups had no deaths during the follow-up period. The follow-up time of the Castor stent group was (18.9 &#177; 5.9) months, the patency rate of the branch stent was 100%, and the follow-up time of the chimney stent was (15.5 &#177; 8.7) months, and the patency rate of the chimney stent was 91.3%. Conclusion: Both the Castor single-branch stent and single-stack stent can be used for the treatment of thoracic aortic disease with cumulative left subclavian artery, with satisfactory near- and medium-term patency rates. Castor stent has a low requirement for left subclavian artery angulation, and a high probability of complete false lumen thrombosis after surgery. Castor stent is preferred for patients with large left subclavian artery angulation, and the long-term effect remains to be observed in follow-up. 
  
 
</p></abstract><kwd-group><kwd>Castor单分支支架，单烟囱支架，主动脉弓部分支重建，主动脉疾病，左锁骨下动脉，假腔血栓化, Castor Single Branch Stent</kwd><kwd> Single Chimney Stent</kwd><kwd> Reconstruction of Partial Branches of the Aortic Arch</kwd><kwd> Aortic Disease</kwd><kwd> Left Subclavian Artery</kwd><kwd> False Lumen Thrombosis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>目的：总结分析Castor单分支支架与单烟囱支架在治疗胸主动脉疾病中重建左锁骨下动脉的经验与体会。方法：回顾性分析2015年12月至2019年6月期间我院因胸主动脉疾病就诊的42例患者临床资料。42例患者中，应用Castor单分支支架19例，其中Stanford B型主动脉夹层13例，主动脉瘤5例，主动脉溃疡1例；应用单烟囱支架的23例，其中Stanford B型主动脉夹层14例，主动脉瘤7例，主动脉溃疡2例，比较两组在围手术期和随访期间的结果，尤其是在主动脉重塑以及内漏等并发症方面。结果：Castor单分支支架及单烟囱支架手术技术成功率均为100%且住院期间无死亡、脑卒中及截瘫患者。19例Castor支架组患者术后I型内漏1人，23例烟囱支架组患者，I型内漏7例，随访期间无死亡。Castor支架组随访时间为(18.9 &#177; 5.9)个月，分支支架通畅率为100%，烟囱支架随访时间为(15.5 &#177; 8.7)个月，烟囱支架通畅率为91.3%。结论：Castor单分支支架与单烟囱支架均可用于治疗累积左锁骨下动脉的胸主动脉疾病，近中期通畅率满意。Castor支架对左侧锁骨下动脉成角要求较低，术后假腔完全血栓化概率高，对于左锁骨下动脉成角大的患者优先考虑Castor支架，远期效果有待继续随访观察。</p></sec><sec id="s2"><title>关键词</title><p>Castor单分支支架，单烟囱支架，主动脉弓部分支重建，主动脉疾病，左锁骨下动脉，假腔血栓化</p></sec><sec id="s3"><title>Analysis and Evaluation of the Efficacy of Castor Single-Branch Stent and Single-Chimney Stent in the Reconstruction of the Left Subclavian Artery in Thoracic Aortic Disease</title><p>Deqiang Qiu<sup>1</sup>, Jun Li<sup>2</sup>, Hai Xin<sup>2</sup>, Weili Liu<sup>2</sup>, Xiaomei Guan<sup>2</sup>, Haofu Wang<sup>2</sup></p><p><sup>1</sup>Qingdao University, Qingdao Shandong</p><p><sup>2</sup>Affiliated Hospital of Qingdao University, Qingdao Shandong</p><p><img src="//html.hanspub.org/file/11-1571719x4_hanspub.png" /></p><p>Received: Nov. 15<sup>th</sup>, 2020; accepted: Dec. 8<sup>th</sup>, 2020; published: Dec. 15<sup>th</sup>, 2020</p><p><img src="//html.hanspub.org/file/11-1571719x5_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Objective: To summarize and analyze the experience of Castor single branch stent and single chimney stent in the reconstruction of the left subclavian artery in the treatment of thoracic aortic disease. Methods: Clinical data of 42 patients admitted to our hospital for aortic disease from December 2015 to June 2019 were retrospectively analyzed. Among the 42 patients, 19 patients were treated with Castor single-branch stent, including 13 patients with Stanford B aortic dissection, 5 patients with aortic aneurysm and 1 patient with aortic ulcer. Among the 23 patients treated with single-chimney stent, 14 were treated with Stanford B aortic dissection, 7 with aortic aneurysm, and 2 with aortic ulcer. Results: The success rate of Castor stent and chimney stent was 100% and there were no death, stroke or paraplegia patients. There was 1 type I endoleak of Castor stent group, and 7 type I endoleak of chimney stent group, both groups had no deaths during the follow-up period. The follow-up time of the Castor stent group was (18.9 &#177; 5.9) months, the patency rate of the branch stent was 100%, and the follow-up time of the chimney stent was (15.5 &#177; 8.7) months, and the patency rate of the chimney stent was 91.3%. Conclusion: Both the Castor single-branch stent and single-stack stent can be used for the treatment of thoracic aortic disease with cumulative left subclavian artery, with satisfactory near- and medium-term patency rates. Castor stent has a low requirement for left subclavian artery angulation, and a high probability of complete false lumen thrombosis after surgery. Castor stent is preferred for patients with large left subclavian artery angulation, and the long-term effect remains to be observed in follow-up.</p><p>Keywords:Castor Single Branch Stent, Single Chimney Stent, Reconstruction of Partial Branches of the Aortic Arch, Aortic Disease, Left Subclavian Artery, False Lumen Thrombosis</p><disp-formula id="hanspub.39164-formula5"><graphic xlink:href="//html.hanspub.org/file/11-1571719x6_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2020 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/11-1571719x7_hanspub.png" /> <img src="//html.hanspub.org/file/11-1571719x8_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>随着腔内技术的发展，血管腔内修复术已经成为治疗胸主动脉疾病的首选方法 [<xref ref-type="bibr" rid="hanspub.39164-ref1">1</xref>]，胸主动脉弓部病变常常累及或临近左锁骨下动脉(Left Subclavian Artery, LSA)，导致近端锚定区不足，以往会放弃腔内手段，改用开放手术或杂交手术治疗 [<xref ref-type="bibr" rid="hanspub.39164-ref2">2</xref>] [<xref ref-type="bibr" rid="hanspub.39164-ref3">3</xref>]。但开放手术需要充分暴露左锁骨下动脉，技术难度高，且会大大增加围术期脑血管意外风险，尤其是对于一般情况较差的患者，预后不佳 [<xref ref-type="bibr" rid="hanspub.39164-ref4">4</xref>]。而杂交手术时间长、创伤大、移植物及切口感染、吻合口漏、动脉闭塞等风险 [<xref ref-type="bibr" rid="hanspub.39164-ref5">5</xref>]。现在应用Castor单分支支架和单烟囱支架延长近端锚定区，并重建主动脉弓部左锁骨下动脉，缩短手术时间，降低手术风险，减少术后并发症。针对Castor单分支支架和单烟囱支架的选择，本文对2015年12月至2019年6月于我院诊治的累及左锁骨下动脉的主动脉疾病的患者进行回顾性分析，分析比较二者的近中期疗效及选择标准。</p></sec><sec id="s6"><title>2. 资料与方法</title><sec id="s6_1"><title>2.1. 一般资料</title><p>2015年12月至2019年6月于我院应用Castor单分支支架或单烟囱支架治疗累积左锁骨下动脉的主动脉疾病患者的基本资料包括性别、年龄、入院诊断、合并症、左锁骨下动脉成角、支架近端锚定区、手术方式、术后并发症(各型内漏、脑卒中、截瘫等)、随访分支支架通畅率等。</p></sec><sec id="s6_2"><title>2.2. 手术及随访</title><p>术前根据CT血管造影(Computerized Tomography Angiography, CTA)明确左锁骨下动脉成角、近端锚定区等选择合适支架。Castor单分支支架手术：常规消毒铺巾后切开股动脉及左桡动脉，置入导丝导管，造影定位左锁骨下动脉位置，循导丝置入Castor支架输送系统，分支支架进入左侧锁骨下动脉，造影确定支架位置合适，释放支架并撤出输送系统，再次造影定位支架位置查看有无内漏。单烟囱支架手术：常规消毒铺巾后穿刺股动脉及左桡动脉，置入导丝导管，造影定位左锁骨下动脉位置，支架主体从股动脉入路输送，烟囱支架从左侧桡动脉入路输送，造影确定支架位置及有无内漏。患者术后均接受随访，门诊预约复查CTA，复查时间为术后3、6、12个月，及以后1年复查1次。</p></sec><sec id="s6_3"><title>2.3. 纳入及排除标准</title><p>所有患者均被诊断为近端锚定区不足(破口位于LSA远端 &lt; 15 mm)，并评估LSA的直径、主要破口位置以及LSA与左颈总动脉之间的距离，以确定烟囱移植物和分支支架移植物尺寸。这些患者均不适合或不愿接受开放手术，并同意接受TEVAR联合LSA重建手术。当入院时未出现持续的顽固性胸痛，破裂，难治性高血压，不稳定的血液动力学或明显的器官缺血的证据时，考虑进行腔内修复。否则，急症行 TEVAR手术。</p></sec></sec><sec id="s7"><title>3. 结果</title><sec id="s7_1"><title>3.1. 一般资料(表1)</title><p>本次实验患者共42例，其中Castor单分支支架组共19例，Stanford B型主动脉夹层13例，主动脉瘤5例，主动脉溃疡1例，男性16例，女性3例，平均年龄(55.1 &#177; 10.9)岁，单烟囱支架组共23例，Stanford B型主动脉夹层14例，主动脉瘤7例，主动脉溃疡2例，男性19例，女性，4例，平均年龄(59.3 &#177; 14.8)岁。性别、年龄、疾病种类、吸烟、糖尿病、高血压对两组支架手术均无明显影响(P &gt; 0.05)。近端锚定区、近端直径、LSA与LCCA的距离、LSA段主动脉直径，两组数据的差异不具有统计学意义(P &gt; 0.05)。单烟囱支架组LSA成角(37.2 &#177; 6.0)小于Castor单分支支架组(55.1 &#177; 10.6)，差异具有统计学意义(P &lt; 0.05)。</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> General information of 42 patient</title></caption><table-wrap id="1_1"><table><tbody><thead><tr><th align="center" valign="middle" >一般情况</th><th align="center" valign="middle" >Castor支架组(19例)</th><th align="center" valign="middle" >单烟囱支架组(23例)</th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >性别</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.490</td></tr><tr><td align="center" valign="middle" >男</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >女</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >年龄</td><td align="center" valign="middle" >55.1 &#177; 10.9</td><td align="center" valign="middle" >59.3 &#177; 14.8</td><td align="center" valign="middle" >0.092</td></tr><tr><td align="center" valign="middle" >Stanford B型主动脉夹层</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >0.612</td></tr><tr><td align="center" valign="middle" >主动脉瘤</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0.769</td></tr></tbody></table></table-wrap><table-wrap id="1_2"><table><tbody><thead><tr><th align="center" valign="middle" >主动脉溃疡</th><th align="center" valign="middle" >1</th><th align="center" valign="middle" >2</th><th align="center" valign="middle" >0.670</th></tr></thead><tr><td align="center" valign="middle" >合并症</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >高血压</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >0.138</td></tr><tr><td align="center" valign="middle" >糖尿病</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0.847</td></tr><tr><td align="center" valign="middle" >吸烟</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >0.519</td></tr><tr><td align="center" valign="middle" >主动脉弓部解剖参数</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >近端锚定区(mm)</td><td align="center" valign="middle" >10.1 &#177; 1.7</td><td align="center" valign="middle" >12.9 &#177; 1.2</td><td align="center" valign="middle" >0.148</td></tr><tr><td align="center" valign="middle" >近端直径(mm)</td><td align="center" valign="middle" >30.2 &#177; 2.2</td><td align="center" valign="middle" >31.4 &#177; 1.5</td><td align="center" valign="middle" >0.993</td></tr><tr><td align="center" valign="middle" >LSA段主动脉直径(mm)</td><td align="center" valign="middle" >30.2 &#177; 1.0</td><td align="center" valign="middle" >31.1 &#177; 21.3</td><td align="center" valign="middle" >0.493</td></tr><tr><td align="center" valign="middle" >LSA与LCCA的距离(mm)</td><td align="center" valign="middle" >10.4 &#177; 1.3</td><td align="center" valign="middle" >13.0 &#177; 1.2</td><td align="center" valign="middle" >0.125</td></tr><tr><td align="center" valign="middle" >LSA成角(˚)</td><td align="center" valign="middle" >55.1 &#177; 10.6</td><td align="center" valign="middle" >37.2 &#177; 6.0</td><td align="center" valign="middle" >0.001</td></tr></tbody></table></table-wrap></table-wrap-group><p>表1. 42例患者一般资料</p></sec><sec id="s7_2"><title>3.2. 手术及随访资料(表2)</title><p>Castor单分支支架组及单烟囱支架组手术均获得成功，且术后均无脑卒中、截瘫及死亡患者。Castor单分支支架组随访时间为(18.9 &#177; 5.9)个月，单烟囱支架随访时间为(15.5 &#177; 8.7)个月，随访期间均无死亡病患者。Castor单分支支架术后I型内漏1例，单烟囱支架组术后I型内漏7例，术后内漏患者均接受随访。Castor单分支支架组患者平均手术时间为(101.1 &#177; 8.4) min，单烟囱支架组患者平均手术时间为(127.8 &#177; 8.7) min，差异具有统计学意义(P &lt; 0.05)。Castor单分支支架组患者平均住院时间为(9.6 &#177; 1.7)天，单烟囱支架组为(9.6 &#177; 1.6)天，差异无统计学意义(P &gt; 0.05)。Castor单分支支架组患者随访期间支架通畅率为100%，单烟囱支架组患者随访期间支架通畅率为91.3%，差异不具有统计学意义(P &gt; 0.05)。Castor单分支支架组术后6月、术后1年主动脉假腔直径显著缩小、真腔直径显著扩大，且较单烟囱支架组变化更明显，差异具有统计学意义(P &lt; 0.05)。Csator单分支支架组术后假腔完全血栓化概率(84.2%)明显高于单烟囱支架组(65.2%)，差距具有统计学意义(P &lt; 0.05)。</p><table-wrap-group id="2"><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Operative and follow-up data of 42 patient</title></caption><table-wrap id="2_1"><table><tbody><thead><tr><th align="center" valign="middle" >手术及随访资料</th><th align="center" valign="middle" >Castor支架组(19例)</th><th align="center" valign="middle" >单烟囱支架组(23例)</th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >平均住院时间(天)</td><td align="center" valign="middle" >9.6 &#177; 1.7</td><td align="center" valign="middle" >9.6 &#177; 1.6</td><td align="center" valign="middle" >0.883</td></tr><tr><td align="center" valign="middle" >手术时间(min)</td><td align="center" valign="middle" >101.1 &#177; 8.4</td><td align="center" valign="middle" >127.8 &#177; 8.7</td><td align="center" valign="middle" >0.028</td></tr><tr><td align="center" valign="middle" >手术成功率</td><td align="center" valign="middle" >100%</td><td align="center" valign="middle" >100%</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >随访时间(月)</td><td align="center" valign="middle" >18.9 &#177; 5.9</td><td align="center" valign="middle" >15.5 &#177; 8.7</td><td align="center" valign="middle" >0.938</td></tr><tr><td align="center" valign="middle" >并发症</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >住院期间死亡</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >随访期间死亡</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >住院期间支架通常率</td><td align="center" valign="middle" >100%</td><td align="center" valign="middle" >100%</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >随访期间支架通畅率</td><td align="center" valign="middle" >100%</td><td align="center" valign="middle" >91.3%</td><td align="center" valign="middle" >0.188</td></tr><tr><td align="center" valign="middle" >脑卒中</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >截瘫</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >I型内漏</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >随访3月I型内漏率</td><td align="center" valign="middle" >1/19</td><td align="center" valign="middle" >6/23</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >随访6月I型内漏率</td><td align="center" valign="middle" >1/19</td><td align="center" valign="middle" >7/23</td><td align="center" valign="middle" >-</td></tr></tbody></table></table-wrap><table-wrap id="2_2"><table><tbody><thead><tr><th align="center" valign="middle" >随访1年I型内漏率</th><th align="center" valign="middle" >1/19</th><th align="center" valign="middle" >7/23</th><th align="center" valign="middle" >-</th></tr></thead><tr><td align="center" valign="middle" >夹层真假腔直径(mm)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >术前真腔直径</td><td align="center" valign="middle" >12.5 &#177; 3.0</td><td align="center" valign="middle" >11.5 &#177; 1.7</td><td align="center" valign="middle" >0.206</td></tr><tr><td align="center" valign="middle" >术前假腔直径</td><td align="center" valign="middle" >19.6 &#177; 2.8</td><td align="center" valign="middle" >21.1 &#177; 2.2</td><td align="center" valign="middle" >0.084</td></tr><tr><td align="center" valign="middle" >术后6个月真腔直径</td><td align="center" valign="middle" >25.1 &#177; 1.4</td><td align="center" valign="middle" >23.8 &#177; 1.4</td><td align="center" valign="middle" >0.010</td></tr><tr><td align="center" valign="middle" >术后6个月假腔直径</td><td align="center" valign="middle" >6.8 &#177; 1.1</td><td align="center" valign="middle" >10.7 &#177; 1.5</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >术后1年真腔直径</td><td align="center" valign="middle" >27.0 &#177; 1.3</td><td align="center" valign="middle" >25.0 &#177; 1.1</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >术后1年假腔直径</td><td align="center" valign="middle" >6.2 &#177; 1.0</td><td align="center" valign="middle" >8.9 &#177; 1.1</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >假腔完全血栓化</td><td align="center" valign="middle" >17/19</td><td align="center" valign="middle" >14/23</td><td align="center" valign="middle" >0.049</td></tr></tbody></table></table-wrap></table-wrap-group><p>表2. 42例患者手术及随访资料</p></sec><sec id="s7_3"><title>3.3. 左锁骨下动脉成角(表3)</title><p>Castor单分支支架组LSA成角(55.1 &#177; 10.6)˚明显大于单烟囱支架组(37.2 &#177; 6.0)˚，差异具有统计学意义(P &lt; 0.05)。LSA成角在0˚~40˚，两组支架发生内漏的情况无显著差异(P &gt; 0.05)，而当LSA成角大于40˚时，Castor单分支支架组内漏的发生显著小于单烟囱支架组，差距具有统计学意义(P &lt; 0.05)。且Castor单分支支架术后内漏与LSA成角无明显的相关关系(P &gt; 0.05)，单烟囱支架术后内漏与LSA成角成显著的正相关关系(P &lt; 0.05)，即LSA成角越大，越容易发生内漏(图1)。</p><p>图1. 主动脉弓分支走行与主动脉弓部相应位置切线之间的角度</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> The left subclavian artery into angle compared with postoperative I type internal leakage occurred relation</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >左锁骨下动脉成角</th><th align="center" valign="middle"  colspan="2"  >Castor支架术后</th><th align="center" valign="middle"  colspan="2"  >烟囱术后I型内漏</th><th align="center" valign="middle"  rowspan="2"  >P值</th></tr></thead><tr><td align="center" valign="middle" >有内漏</td><td align="center" valign="middle" >无内漏</td><td align="center" valign="middle" >有内漏</td><td align="center" valign="middle" >无内漏</td></tr><tr><td align="center" valign="middle" >0˚~40˚</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >&gt;40˚</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.002</td></tr></tbody></table></table-wrap><p>表3. 左锁骨下动脉成角与术后I型内漏发生关系对比</p></sec><sec id="s7_4"><title>3.4. 关于内漏率的生存分析</title><p>Castor单分支支架术后内漏1例，单烟囱支架组术后内漏7例，两组支架对内漏的影响差异存在具有统计学意义(P &lt; 0.05)，且Castor支架组内漏率(5.3%)显著小于烟囱支架组(30.4%)。根据随访结果绘制的K-M生存曲线(图2)可以看出，Castor单分支支架组手术效果显著好于单烟囱支架组，且差异具有统计学意义(P = 0.048 &lt; 0.05)。</p><p>图2. Castor支架组与烟囱支架组K-M法生存分析结果</p></sec><sec id="s7_5"><title>3.5. 统计学分析</title><p>采用SPSS25进行统计学分析。计数资料采用卡方检验，相关性分析采用Spearman相关性分析，Logistic回归模型分析影响因素，Kaplan-Meier生存曲线进行生存分析，P &lt; 0.05说明差异具有统计学意义。</p></sec></sec><sec id="s8"><title>4. 讨论</title><p>目前胸主动脉腔内修复术(thoracic endovascular aortic repair, TEVAR)已经成为治疗胸主动脉夹层、胸主动脉瘤等胸主动脉疾病的主要手段 [<xref ref-type="bibr" rid="hanspub.39164-ref6">6</xref>]。累及主动脉弓分支，尤其是左锁骨下动脉的胸主动脉疾病，由于近端锚定区不足，常规的胸主动脉腔内修复术受到限制。Caronno等认为覆盖左锁骨下动脉不会增加脑血管意外和脊髓缺血 [<xref ref-type="bibr" rid="hanspub.39164-ref7">7</xref>] [<xref ref-type="bibr" rid="hanspub.39164-ref8">8</xref>]。但是近几年，随着对TEVAR手术的认知进一步加深，国内外学者倾向于认为，左锁骨下动脉完全封堵后不仅会导致左上肢缺血，更会增加中风和脊髓损伤的风险 [<xref ref-type="bibr" rid="hanspub.39164-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.39164-ref10">10</xref>]。Buth等研究表明，预防性的重建左锁骨下动脉可以有效降低脑卒中及脊髓损伤的概率 [<xref ref-type="bibr" rid="hanspub.39164-ref11">11</xref>] [<xref ref-type="bibr" rid="hanspub.39164-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.39164-ref13">13</xref>]。因此，重建左锁骨下动脉对改善患者生活质量、降低脑血管意外有重要意义 [<xref ref-type="bibr" rid="hanspub.39164-ref14">14</xref>]。目前国内重建左锁骨下动脉、扩展近端锚定区主要方法为应用Castor单分支支架或者单烟囱支架。Castor分支型主动脉覆膜支架是第一款用于完全腔内治疗累及左锁骨下动脉，或破口与左锁骨下动脉距离 &lt; 15 mm胸主动脉疾病的分支型覆膜支架系统。Castor单分支支架具有操作简单、贴附性强、有效降低内漏风险等优势 [<xref ref-type="bibr" rid="hanspub.39164-ref15">15</xref>]。烟囱技术由Greenberg等 [<xref ref-type="bibr" rid="hanspub.39164-ref16">16</xref>] 于2003年首次报道，具有创伤小、技术要求低等优点。研究报道，烟囱支架技术术后内漏发生率为15%~30% [<xref ref-type="bibr" rid="hanspub.39164-ref17">17</xref>] [<xref ref-type="bibr" rid="hanspub.39164-ref18">18</xref>] [<xref ref-type="bibr" rid="hanspub.39164-ref19">19</xref>] [<xref ref-type="bibr" rid="hanspub.39164-ref20">20</xref>]。本组实验中，Castor单分支支架19例，术后及随访内漏1例，支架通畅率100%；单烟囱支架23例，术后及随访内漏7例，支架通畅率91.3%。随访发现单烟囱支架组术后内漏率及近中期支架通畅率不及Castor支架。主动脉弓部的解剖条件为导致TEVAR术后内漏的重要原因 [<xref ref-type="bibr" rid="hanspub.39164-ref21">21</xref>] [<xref ref-type="bibr" rid="hanspub.39164-ref22">22</xref>]。近端锚定区、近端直径、LSA段主动脉直径、LSA与LCCA的距离对两组支架的影响不明显。左锁骨下动脉成角超过40˚，单烟囱支架组术后内漏率明显升高，Castor单分支支架优势较明显，而左锁骨下动脉成角不大于40˚时，单烟囱支架内漏率与Castor单分支支架差别不明显。烟囱支架组内漏率明显高于Castor支架组，且LSA成角越大发生内漏的风险越高，而Castor支架内漏的发生与LSA成角无明显的相关关系。术后假腔完全血栓化为TEVAR术后主动脉重建的重要评价标准。假腔完全血栓化往往提示管腔重塑良好，是TEVAR手术取得良好预后结果的重要临床指标 [<xref ref-type="bibr" rid="hanspub.39164-ref23">23</xref>] [<xref ref-type="bibr" rid="hanspub.39164-ref24">24</xref>] [<xref ref-type="bibr" rid="hanspub.39164-ref25">25</xref>]。本组实验中Castor单分支支架组术后假腔完全血栓化概率明显高于单烟囱支架组，这表明Castor单分支支架更有利于术后管腔重塑。</p></sec><sec id="s9"><title>5. 总结</title><p>Castor单分支支架与单烟囱支架均可用于近端锚定区不足时主动脉弓左锁骨下动脉的重建，左锁骨下动脉成角较小(&lt;40˚)的情况单烟囱支架安全有效，而Castor单分支支架受左锁骨下动脉成角的影响较小，适用范围更广，左锁骨下动脉成角较大时选择Castor单分支支架可以有效避免术后内漏。两种支架近中期通畅率较好，远期通畅率有待进一步观察。</p></sec><sec id="s10"><title>文章引用</title><p>邱德强,李 君,辛 海,刘伟丽,官笑梅,王豪夫. Castor单分支支架与单烟囱支架在胸主动脉疾病中重建左侧锁骨下动脉的疗效分析及评价Analysis and Evaluation of the Efficacy of Castor Single-Branch Stent and Single-Chimney Stent in the Reconstruction of the Left Subclavian Artery in Thoracic Aortic Disease[J]. 临床医学进展, 2020, 10(12): 2918-2925. https://doi.org/10.12677/ACM.2020.1012441</p></sec><sec id="s11"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.39164-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Noor, N., Sadat, U., Hayes, P.D., et al. (2008) Management of the Left Subclavian Artery during Endovascular Repair of the Thoracic Aorta. Journal of Endovascular Therapy, 15, 168-176. &lt;br&gt;https://doi.org/10.1583/08-2406.1</mixed-citation></ref><ref id="hanspub.39164-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Canaud, L., Hireche, K., D’annoville, T., et al. (2011) Hybrid Aortic Arch Repair for a Ruptured and Infected Penetrating Atherosclerotic Ulcer of the Aortic Arch. Annals of Vascular Surgery, 25, 266.e5-266.e7.  
&lt;br&gt;https://doi.org/10.1016/j.avsg.2010.06.011</mixed-citation></ref><ref id="hanspub.39164-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Antoniou, G.A., Mireskandari, M., Bicknell, C.D., et al. (2010) Hybrid Repair of the Aortic Arch in Patients with Extensive Aortic Disease. European Journal of Vascular and Endovascular Surgery: The Official Journal of the European Society for Vascular Surgery, 40, 715-721. &lt;br&gt;https://doi.org/10.1016/j.ejvs.2010.08.024</mixed-citation></ref><ref id="hanspub.39164-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Misfeld, M., Leontyev, S., Borger, M.A., et al. (2012) What Is the Best Strategy for Brain Protection in Patients Undergoing Aortic Arch Surgery? A Single Center Experience of 636 Patients. Annals of Thoracic Surgery, 93, 1502-1508. &lt;br&gt;https://doi.org/10.1016/j.athoracsur.2012.01.106</mixed-citation></ref><ref id="hanspub.39164-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Czerny, M., Weigang, E., Sodeck, G., et al. (2012) Targeting Landing Zone 0 by Total Arch Rerouting and TEVAR: Midterm Results of a Transcontinental Registry. Annals of Thoracic Surgery, 94, 84-89.  
&lt;br&gt;https://doi.org/10.1016/j.athoracsur.2012.03.024</mixed-citation></ref><ref id="hanspub.39164-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Matsumura, J.S., Lee, W.A., Mitchell, R.S., et al. (2009) The Society for Vascular Surgery Practice Guidelines: Management of the Left Subclavian Artery with Thoracic Endovascular Aortic Repair. Journal of Vascular Surgery, 50, 1155-1158. &lt;br&gt;https://doi.org/10.1016/j.jvs.2009.08.090</mixed-citation></ref><ref id="hanspub.39164-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Caronno, R., Piffaretti, G., Tozzi, M., et al. (2006) Intentional Coverage of the Left Subclavian Artery during Endovascular Stent Graft Repair for Thoracic Aortic Disease. Surgical Endoscopy, 20, 915-918.  
&lt;br&gt;https://doi.org/10.1007/s00464-005-0526-6</mixed-citation></ref><ref id="hanspub.39164-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Thomas, S., Maldonado, et al. (2013) Left Subclavian Artery Coverage during Thoracic Endovascular Aortic Aneurysm Repair Does Not Mandate Revascularization. Journal of Vascular Surgery, 45, 90-94.  
&lt;br&gt;https://doi.org/10.1016/j.jvs.2012.06.101</mixed-citation></ref><ref id="hanspub.39164-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Sobocinski, J., et al. (2016) The Effect of Left Subclavian Artery Coverage in Thoracic Endovascular Aortic Repair. Annals of Thoracic Surgery, 101, 810-817. &lt;br&gt;https://doi.org/10.1016/j.athoracsur.2015.08.069</mixed-citation></ref><ref id="hanspub.39164-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Bradshaw, R.J., Ahanchi, S.S., Powell, O., et al. (2017) Left Subclavian Artery Revascularization in Zone 2 Thoracic Endovascular Aortic Repair Is Associated with Lower Stroke Risk across All Aortic Diseases. Journal of Vascular Surgery, 65, 1270-1279. &lt;br&gt;https://doi.org/10.1016/j.jvs.2016.10.111</mixed-citation></ref><ref id="hanspub.39164-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Buth, J., Harris, P.L., Hobo, R., et al. (2007) Neurologic Complications Associated with Endovascular Repair of Thoracic Aortic Pathology: Incidence and Risk Factors. A Study from the European Collaborators on Stent/Graft Techniques for Aortic Aneurysm Repair (EUROSTAR) Registry. Journal of Vascular Surgery, 46, 1103-111100.  
&lt;br&gt;https://doi.org/10.1016/j.jvs.2007.08.020</mixed-citation></ref><ref id="hanspub.39164-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Waterford, S.D., Chou, D., Bombien, Re., et al. (2015) Left Subclavian Arterial Coverage and Stroke during Thoracic Aortic Endografting: A Systematic Review. Annals of Thoracic Surgery, 101, 381-389.  
&lt;br&gt;https://doi.org/10.1016/j.athoracsur.2015.05.138</mixed-citation></ref><ref id="hanspub.39164-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, L., et al. (2015) Alternative Management of the Left Subclavian Artery in Thoracic Endovascular Aortic Repair for Aortic Dissection: A Single-Center Experience. European Journal of Medical Research, 20, Article No. 57.  
&lt;br&gt;https://doi.org/10.1186/s40001-015-0147-z</mixed-citation></ref><ref id="hanspub.39164-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Tang, Y.F., et al. (2016) Left Subclavian Artery Fenestration: A Novel Treatment Strategy for Acute Type A Aortic Dissection. Annals of Thoracic Surgery, 101, 95-99.</mixed-citation></ref><ref id="hanspub.39164-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Lu, Q.S., Feng, J.X., Zhou, J., et al. (2015) Endovascular Repair by Customized Branched Stent-Graft: A Promising Treatment for Chronic Aortic Dissection Involving the Arch Branches. Journal of Thoracic &amp; Cardiovascular Surgery, 150, 1631-1638.e5. &lt;br&gt;https://doi.org/10.1016/j.jtcvs.2015.08.032</mixed-citation></ref><ref id="hanspub.39164-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Greenberg, R.K., Clair, D., Srivastava, S., et al. (2003) Should Patients with Challenging Anatomy Be Offered Endovascular Aneurysm Repair? Journal of Vascular Surgery, 38, 990-996.  
&lt;br&gt;https://doi.org/10.1016/S0741-5214(03)00896-6</mixed-citation></ref><ref id="hanspub.39164-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Parmer, S.S., Carpenter, J.P., Stavropoulos, S.W., et al. (2006) Endoleaks after Endovascular Repair of Thoracic Aortic Aneurysms. Journal of Vascular Surgery, 44, 447-452. &lt;br&gt;https://doi.org/10.1016/j.jvs.2006.05.041</mixed-citation></ref><ref id="hanspub.39164-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Preventza, O., Iii, G.H.W., Ramaiah, V.G., et al. (2008) Management of Endoleaks Associated with Endovascular Treatment of Descending Thoracic Aortic Diseases. Journal of Vascular Surgery, 48, 69-73.  
&lt;br&gt;https://doi.org/10.1016/j.jvs.2008.02.032</mixed-citation></ref><ref id="hanspub.39164-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Novak, Z., Pearce, B.J., Patterson, M.A., et al. (2014) Experience with CHIMPS Endovascular Techniques and Outcomes in Comparison with Propensity-Matched Controls. Journal of Vascular Surgery, 59, 559.  
&lt;br&gt;https://doi.org/10.1016/j.jvs.2013.11.020</mixed-citation></ref><ref id="hanspub.39164-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Wilson, A., Zhou, S., Bachoo, P., et al. (2013) Systematic Review of Chimney and Periscope Grafts for Endovascular Aneurysm Repair. British Journal of Surgery, 100, 1557-1564. &lt;br&gt;https://doi.org/10.1002/bjs.9274</mixed-citation></ref><ref id="hanspub.39164-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Sugiura, K., Sonesson, B., Akesson, M., et al. (2009) The Applicability of Chimney Grafts in the Aortic Arch. The Journal of Cardiovascular Surgery, 50, 475-481.</mixed-citation></ref><ref id="hanspub.39164-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Malina, M., Resch, T.B. and Sonesson, B. (2008) Evar and Complex Anatomy: An Update on Fenestrated and Branched Stent Grafts. Scandinavian Journal of Surgery, 97, 195-204. &lt;br&gt;https://doi.org/10.1177/145749690809700226</mixed-citation></ref><ref id="hanspub.39164-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Mussa, F.F., Horton, J.D., Moridzadeh, R., et al. (2016) Acute Aortic Dissection and Intramural Hematoma. JAMA, 316, 754. &lt;br&gt;https://doi.org/10.1001/jama.2016.10026</mixed-citation></ref><ref id="hanspub.39164-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Piazza, M., et al. (2017) Definition of Type II Endoleak Risk Based on Preoperative Anatomical Characteristics. Journal of Endovascular Therapy, 24, 566-572. &lt;br&gt;https://doi.org/10.1177/1526602817712511</mixed-citation></ref><ref id="hanspub.39164-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Kamman, A.V., Brunkwall, J., Verhoeven, E.L., et al. (2016) Predictors of Aortic Growth in Uncomplicated Type B Aortic Dissection from the Acute Dissection Stent Grafting or Best Medical Treatment (ADSORB) Database. Journal of Vascular Surgery, 65, 964-971.e3. &lt;br&gt;https://doi.org/10.1016/j.jvs.2016.09.033</mixed-citation></ref></ref-list></back></article>